17:29 EDT C4 Therapeutics (CCCC) files to sell 4.87M shares of common stock for holders
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCCC:
- C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
- C4 Therapeutics Appoints New Chief Scientific Officer
- C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
- C4 Therapeutics announces next steps for CFT1946
- C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial